- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 14.34M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $53.37M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $55.63M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $17.9M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $23.31M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $102.51M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $113.65M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $190.61M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $202.74M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 14.7M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $1.81M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$126K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $208.54M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $212.27M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.31 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.31 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $15.07M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $6.41M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$4.51M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$2.51M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $18.98M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $10.05M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $29.02M |